Published in Psychopharmacology (Berl) on July 03, 2012
Pathological Overeating: Emerging Evidence for a Compulsivity Construct. Neuropsychopharmacology (2016) 0.86
The overlap between binge eating disorder and substance use disorders: Diagnosis and neurobiology. J Behav Addict (2013) 0.84
The role of the opioid system in binge eating disorder. CNS Spectr (2015) 0.79
Cognitive biases in binge eating disorder: the hijacking of decision making. CNS Spectr (2015) 0.78
Attentional bias to food cues in youth with loss of control eating. Appetite (2014) 0.78
The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjects. J Clin Pharmacol (2013) 0.77
Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype. Neuropsychopharmacology (2016) 0.76
Neurobiological features of binge eating disorder. CNS Spectr (2015) 0.76
Central nervous system biomarkers for antiobesity drug development. Drug Discov Today (2013) 0.75
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA (2006) 13.15
Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry (1974) 4.76
The assessment of binge eating severity among obese persons. Addict Behav (1982) 4.02
The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci (2009) 3.79
Prevalence and correlates of eating disorders in adolescents. Results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry (2011) 3.73
'Liking' and 'wanting' food rewards: brain substrates and roles in eating disorders. Physiol Behav (2009) 2.94
Reward processing by the opioid system in the brain. Physiol Rev (2009) 2.46
Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev (2010) 2.21
Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport (2001) 2.19
A description of eating disorders in 1932. Am J Psychiatry (1990) 2.05
The neuropsychiatry of impulsivity. Curr Opin Psychiatry (2007) 1.90
Compulsive overeating as an addiction disorder. A review of theory and evidence. Appetite (2009) 1.88
The addiction-stroop test: Theoretical considerations and procedural recommendations. Psychol Bull (2006) 1.87
Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology (Berl) (2004) 1.66
The neurobiology of substance and behavioral addictions. CNS Spectr (2006) 1.59
Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci (2003) 1.54
Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology (1998) 1.54
Neurobiology of addiction. An integrative review. Biochem Pharmacol (2007) 1.52
Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev (2002) 1.49
Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry (2010) 1.45
Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature (1993) 1.45
Feeding and reward: perspectives from three rat models of binge eating. Physiol Behav (2011) 1.44
What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neurosci Biobehav Rev (2010) 1.33
Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav Rev (2010) 1.15
Appetite and reward. Front Neuroendocrinol (2009) 1.14
Overlaps in the nosology of substance abuse and overeating: the translational implications of "food addiction". Curr Drug Abuse Rev (2011) 1.14
Neuropsychological consequences of opiate use. Neuropsychol Rev (2007) 1.13
Psychological aspects of severe obesity. Am J Clin Nutr (1992) 1.09
Comparison of binge eating disorder and bulimia nervosa in a community sample. Int J Eat Disord (2001) 1.08
Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Mol Psychiatry (2011) 1.06
From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour. Int J Neuropsychopharmacol (2009) 1.03
Negative mood increases selective attention to food cues and subjective appetite. Appetite (2009) 1.03
Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology (2012) 1.02
The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology (Berl) (2000) 1.02
Opioid receptor modulation of hedonic taste preference and food intake: a single-dose safety, pharmacokinetic, and pharmacodynamic investigation with GSK1521498, a novel μ-opioid receptor inverse agonist. J Clin Pharmacol (2011) 0.98
Socio-economic determinants of suicide: an ecological analysis of 35 countries. Soc Psychiatry Psychiatr Epidemiol (2010) 0.98
Noradrenergic stimulation enhances human action monitoring. J Neurosci (2005) 0.97
Cognitive biases to healthy and unhealthy food words predict change in BMI. Obesity (Silver Spring) (2010) 0.93
Attentional and approach biases for pictorial food cues. Influence of external eating. Appetite (2008) 0.93
Opioidergic consequences of dietary-induced binge eating. Physiol Behav (2011) 0.93
Multiple-dose safety, pharmacokinetics, and pharmacodynamics of the μ-opioid receptor inverse agonist GSK1521498. J Clin Pharmacol (2011) 0.92
Regional mu-opioid receptor binding in insular cortex is decreased in bulimia nervosa and correlates inversely with fasting behavior. J Nucl Med (2005) 0.92
Increased food and water intake produced in rats by opiate receptor agonists. Psychopharmacology (Berl) (1981) 0.91
The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects. Int J Neuropsychopharmacol (2011) 0.90
Prevalence of suicidal thoughts and attempts among pregnant Pakistani women. Acta Obstet Gynecol Scand (2010) 0.90
Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in mice. Eur J Pharmacol (2000) 0.87
A comparison of two approaches to the assessment of binge eating in obesity. Int J Eat Disord (1998) 0.87
Selective actions of central mu and kappa opioid antagonists upon sucrose intake in sham-fed rats. Brain Res (1995) 0.87
High-dose naltrexone therapy and dietary counseling for obesity. Biol Psychiatry (1987) 0.87
Opiates, overeating and obesity: a psychogenetic analysis. Int J Obes (Lond) (2011) 0.86
Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. Clin Ther (2006) 0.84
Sensorimotor gating and attentional set-shifting are improved by the mu-opioid receptor agonist morphine in healthy human volunteers. Int J Neuropsychopharmacol (2008) 0.83
Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet. Pharmacol Biochem Behav (1981) 0.83
Effects of mu-opioid receptor agonists on circulatory responses to simulated haemorrhage in conscious rabbits. Br J Pharmacol (1990) 0.82
High-dose naloxone affects task performance in normal subjects. Psychiatry Res (1983) 0.82
Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome. Biol Psychiatry (1986) 0.82
Mu opioid receptor-mediated modulation of synaptic currents in dentate granule cells of rat hippocampus. J Neurophysiol (1992) 0.81
Placebo response in binge eating disorder. Int J Eat Disord (2007) 0.81
Effect of naltrexone on food intake, hunger, and satiety in obese men. Physiol Behav (1987) 0.81
Prediction of weight loss and regain following dietary, lifestyle, and pharmacologic intervention. Clin Pharmacol Ther (2012) 0.81
Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice. J Pharmacol Exp Ther (1994) 0.80
Modifications of nutrient selection induced by naloxone in rats. Psychopharmacology (Berl) (1981) 0.79
Birth outcomes following self-inflicted poisoning during pregnancy, California, 2000 to 2004. J Obstet Gynecol Neonatal Nurs (2011) 0.79
Impaired water maze learning performance in mu-opioid receptor knockout mice. Brain Res Mol Brain Res (2003) 0.79
Effect of 12-hour infusion of naloxone on mood and cognition in normal male volunteers. Biol Psychiatry (1992) 0.77
Globalisation and suicide: an empirical investigation in 35 countries over the period 1980-2006. Health Place (2011) 0.75
Effect of naltrexone on mood and cognitive functioning among overweight men. Biol Psychiatry (1986) 0.75
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91
Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 4.84
Whole-brain anatomical networks: does the choice of nodes matter? Neuroimage (2009) 4.43
Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry (2004) 3.85
Network-based statistic: identifying differences in brain networks. Neuroimage (2010) 3.60
Amygdala-frontal connectivity during emotion regulation. Soc Cogn Affect Neurosci (2007) 3.43
Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry (2005) 3.35
Human brain networks in health and disease. Curr Opin Neurol (2009) 3.28
Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry (2008) 3.22
Modular and hierarchically modular organization of brain networks. Front Neurosci (2010) 3.06
Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder. Am J Psychiatry (2006) 2.90
Abnormal brain structure implicated in stimulant drug addiction. Science (2012) 2.85
Hierarchical modularity in human brain functional networks. Front Neuroinform (2009) 2.76
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60
Schizophrenia, neuroimaging and connectomics. Neuroimage (2012) 2.49
Beyond threat: amygdala reactivity across multiple expressions of facial affect. Neuroimage (2005) 2.47
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov (2012) 2.44
Efficient physical embedding of topologically complex information processing networks in brains and computer circuits. PLoS Comput Biol (2010) 2.37
Selective attention to angry faces in clinical social phobia. J Abnorm Psychol (2004) 2.30
Disrupted modularity and local connectivity of brain functional networks in childhood-onset schizophrenia. Front Syst Neurosci (2010) 2.22
Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science (2008) 2.20
Network scaling effects in graph analytic studies of human resting-state FMRI data. Front Syst Neurosci (2010) 2.13
Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry (2010) 2.13
Disrupted axonal fiber connectivity in schizophrenia. Biol Psychiatry (2010) 2.12
Attention bias to threat in maltreated children: implications for vulnerability to stress-related psychopathology. Am J Psychiatry (2005) 2.08
Cognitive fitness of cost-efficient brain functional networks. Proc Natl Acad Sci U S A (2009) 2.07
Fetal testosterone influences sexually dimorphic gray matter in the human brain. J Neurosci (2012) 2.05
Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am J Psychiatry (2012) 2.05
Differential activation of the amygdala and the 'social brain' during fearful face-processing in Asperger Syndrome. Neuropsychologia (2006) 2.02
The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours. Psychopharmacology (Berl) (2014) 2.01
Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain (2011) 2.00
Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology (2010) 1.98
Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci (2006) 1.95
Selective orienting of attention to masked threat faces in social anxiety. Behav Res Ther (2002) 1.93
The rich club of the C. elegans neuronal connectome. J Neurosci (2013) 1.92
Cognitive effort drives workspace configuration of human brain functional networks. J Neurosci (2011) 1.92
Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry (2007) 1.92
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci (2013) 1.91
Genetic influences on cost-efficient organization of human cortical functional networks. J Neurosci (2011) 1.90
Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry (2008) 1.89
Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry (2004) 1.87
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects. Br J Clin Pharmacol (2008) 1.83
Orienting and maintenance of gaze to facial expressions in social anxiety. J Abnorm Psychol (2006) 1.80
Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Arch Gen Psychiatry (2006) 1.78
Atypical neural self-representation in autism. Brain (2009) 1.73
Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry (2007) 1.71
Patterns of neural connectivity during an attention bias task moderate associations between early childhood temperament and internalizing symptoms in young adulthood. Biol Psychiatry (2013) 1.68
Shared neural circuits for mentalizing about the self and others. J Cogn Neurosci (2010) 1.67
Eye movements to smoking-related pictures in smokers: relationship between attentional biases and implicit and explicit measures of stimulus valence. Addiction (2003) 1.66
Attention bias toward threat in pediatric anxiety disorders. J Am Acad Child Adolesc Psychiatry (2008) 1.64
Prediction error during retrospective revaluation of causal associations in humans: fMRI evidence in favor of an associative model of learning. Neuron (2004) 1.64
Simple models of human brain functional networks. Proc Natl Acad Sci U S A (2012) 1.63
Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One (2010) 1.62
Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function. Brain (2005) 1.61
Attentional biases for alcohol cues in heavy and light social drinkers: the roles of initial orienting and maintained attention. Psychopharmacology (Berl) (2004) 1.59
What can spontaneous fluctuations of the blood oxygenation-level-dependent signal tell us about psychiatric disorders? Curr Opin Psychiatry (2010) 1.57
The relationship between motor deficit and hemisphere activation balance after stroke: A 3T fMRI study. Neuroimage (2006) 1.55
The anatomical distance of functional connections predicts brain network topology in health and schizophrenia. Cereb Cortex (2012) 1.55
Endogenous human brain dynamics recover slowly following cognitive effort. PLoS One (2009) 1.55
Reproducibility of graph metrics of human brain functional networks. Neuroimage (2009) 1.54
General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance. Biol Psychiatry (2011) 1.54
The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain (2007) 1.53
Change detection in children with autism: an auditory event-related fMRI study. Neuroimage (2005) 1.52
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction. Int J Neuropsychopharmacol (2012) 1.52
Cognitive relevance of the community structure of the human brain functional coactivation network. Proc Natl Acad Sci U S A (2013) 1.49
Brain hyper-reactivity to auditory novel targets in children with high-functioning autism. Brain (2008) 1.49
Quantitative multi-parameter mapping of R1, PD(*), MT, and R2(*) at 3T: a multi-center validation. Front Neurosci (2013) 1.45
Molecular imaging of the dopaminergic system and its association with human cognitive function. Biol Psychiatry (2006) 1.44
Task instructions modulate neural responses to fearful facial expressions. Biol Psychiatry (2003) 1.43
Biological sex affects the neurobiology of autism. Brain (2013) 1.40
Brain surface anatomy in adults with autism: the relationship between surface area, cortical thickness, and autistic symptoms. JAMA Psychiatry (2013) 1.35
Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry (2006) 1.35
Attentional bias for emotional faces in children with generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry (2008) 1.35
Validation of a quantitative magnetic resonance method for measuring human body composition. Obesity (Silver Spring) (2008) 1.34
Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans. Synapse (2008) 1.34
Relationship between trait anxiety, prefrontal cortex, and attention bias to angry faces in children and adolescents. Biol Psychol (2008) 1.34
Anxiety and orienting of gaze to angry and fearful faces. Biol Psychol (2007) 1.33
Integrated strategy for improving functional connectivity mapping using multiecho fMRI. Proc Natl Acad Sci U S A (2013) 1.32
Hubs of brain functional networks are radically reorganized in comatose patients. Proc Natl Acad Sci U S A (2012) 1.31
Eye movements to smoking-related cues: effects of nicotine deprivation. Psychopharmacology (Berl) (2003) 1.30
Selective processing of cannabis cues in regular cannabis users. Drug Alcohol Depend (2006) 1.30
Learning-related human brain activations reflecting individual finances. Neuron (2007) 1.30
Biases in visual orienting to negative and positive scenes in dysphoria: An eye movement study. J Abnorm Psychol (2007) 1.30